Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 202 to 251 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HSKIN17 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.181398\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.563416\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.321961038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIN\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYADENYLATE-BINDING PROTEIN 1 (POLY(A)-BINDING PROTEIN 1) (PABP 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0422886\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.131347\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.321960913\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PABPC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CARNITINE O-ACETYLTRANSFERASE (EC 2.3.1.7) (CARNITINE ACETYLASE) (CAT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.193666\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.601521\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.321960497\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CRAT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR JUN-B. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.339248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.0574\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.32083223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
JUNB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR JUN-D. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.457984\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.42825\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.320660949\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
JUND\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SYNTAXIN 18. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.125691\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.392103\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.320556078\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STX18\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANDROGEN-INDUCED 1; CGI-103 PROTEIN; ANDROGEN INDUCED PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.281345\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.87768\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.320555328\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AIG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHENYLALANINE-4-HYDROXYLASE (EC 1.14.16.1) (PAH) (PHE-4- MONOOXYGENASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.48249\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.62476\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.320555013\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BA127L20.1 (NOVEL GLUTATHIONE-S-TRANSFERASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.135419\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.422452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.320554761\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GSTO2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTATHIONE TRANSFERASE OMEGA 1 (EC 2.5.1.18) (GSTO 1-1). \vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.155654\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.485577\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.320554721\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
GSTO1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP SYNTHASE B CHAIN, MITOCHONDRIAL PRECURSOR (EC 3.6.3.14). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
ATP5F1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RD PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
J DOMAIN CONTAINING PROTEIN 1. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
DNAJC12\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PP3111 PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
DUS1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SORTING NEXIN 13 (RGS DOMAIN- AND PHOX DOMAIN-CONTAINING PROTEIN) (RGS-PX1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.147132\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.458992\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.320554607\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNX13\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DR1-ASSOCIATED PROTEIN 1; NEGATIVE COFACTOR 2 ALPHA; DR1-ASSOCIATED COREPRESSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.215654\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.675264\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.319362501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DRAP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMALL NUCLEAR RIBONUCLEOPROTEIN SM D3 (SNRNP CORE PROTEIN D3) (SM-D3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.923366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.89146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.319342478\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNRPD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 10 (EIF-3 THETA) (EIF3 P167) (EIF3 P180) (EIF3 P185) (EIF3A). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.194219\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.608459\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.319198171\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF3A\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 4 (EIF-3 DELTA) (EIF3 P44) (EIF-3 RNA-BINDING SUBUNIT) (EIF3 P42) (EIF3G). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
EIF3G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.535221\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.68161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.318278911\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
B9D2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SAD1/UNC-84 PROTEIN-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.240086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.755227\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.317899122\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UNC84A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0985042\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.309963\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.317793414\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
XPR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMALL NUCLEAR RIBONUCLEOPROTEIN SM D2 (SNRNP CORE PROTEIN D2) (SM-D2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.978717\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.08483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.317267726\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNRPD2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPLICING FACTOR 3B SUBUNIT 1 (SPLICEOSOME ASSOCIATED PROTEIN 155) (SAP 155) (SF3B155) (PRE-MRNA SPLICING FACTOR SF3B 155 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.764466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.41141\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.317020333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SF3B1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VINCULIN (METAVINCULIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.253265\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.799038\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.316962397\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VCL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.331603\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.04653\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.316859526\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF2B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NY-REN-62 ANTIGEN (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.099292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.313795\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.316423142\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF21A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN-LIKE PROTEIN KIF2 (KINESIN-2) (HK2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.425718\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.34686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.31608185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF2A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
JUN DIMERIZATION PROTEIN. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.193648\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.614336\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.315215127\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTO-ONCOGENE PROTEIN C-FOS (CELLULAR ONCOGENE FOS) (G0/G1 SWITCH REGULATORY PROTEIN 7). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FOS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FOS-RELATED ANTIGEN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.151666\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.481506\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.314982576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOSL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN FOSB (G0/G1 SWITCH REGULATORY PROTEIN 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.149853\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.475769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.31497008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOSB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FOS-RELATED ANTIGEN 1 (FRA-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.144083\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.457513\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.31492657\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOSL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DNA POLYMERASE EPSILON, CATALYTIC SUBUNIT A (EC 2.7.7.7) (DNA POLYMERASE II SUBUNIT A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.259541\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.824492\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.314788985\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLE\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPORTIN BETA-3 SUBUNIT (KARYOPHERIN BETA-3 SUBUNIT) (RAN-BINDING PROTEIN 5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.162809\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.517346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.314700413\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RANBP5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAN-GTP BINDING PROTEIN (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.151819\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.482771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.31447415\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RANBP6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.887185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.82668\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.313861137\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BTF3L4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR BTF3 (RNA POLYMERASE B TRANSCRIPTION FACTOR 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.737493\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.35516\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.313139235\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BTF3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, CATALYTIC ALPHA-1 CHAIN (EC 2.7.1.-) (AMPK ALPHA-1 CHAIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.547661\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.75288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312434964\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, BETA-2 SUBUNIT (AMPK BETA-2 CHAIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.404521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.29474\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312434157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAB2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, GAMMA-1 SUBUNIT (AMPK GAMMA-1 CHAIN) (AMPKG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.180475\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.577642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312433999\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, GAMMA-3 SUBUNIT (AMPK GAMMA-3 CHAIN) (AMPK GAMMA3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.177169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.567061\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312433759\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAG3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, CATALYTIC ALPHA-2 CHAIN (EC 2.7.1.-) (AMPK ALPHA-2 CHAIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.630538\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.01815\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312433664\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, GAMMA-2 SUBUNIT (AMPK GAMMA-2 CHAIN) (AMPK GAMMA2) (H91620P). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.221131\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.70777\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312433418\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, BETA-1 SUBUNIT (AMPK BETA-1 CHAIN) (AMPKB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.355846\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.13895\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312433382\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKAB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR BTF3 HOMOLOG 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.625831\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.00343\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312379769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PXR2B PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.253658\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.812851\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.312059652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PEX5L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NASCENT-POLYPEPTIDE-ASSOCIATED COMPLEX ALPHA POLYPEPTIDE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.804734\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.57998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.311914821\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALPHA-NAC PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.755644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.42272\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.311899023\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.743299\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.38318\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.311893772\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/